Aarthi Jayanthan
Pre Clinical R&D
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.
Journal: Leukemia
Published: March 18, 2026
RSK1 dependency in FLT3-ITD acute myeloid leukemia.
Journal: Blood cancer journal
Published: October 03, 2024
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
Journal: Nature communications
Published: September 26, 2024
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 04, 2023
Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia.
Journal: Journal of pediatric hematology/oncology
Published: December 05, 2022
The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway.
Journal: Current eye research
Published: October 22, 2021
Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib.
Journal: Current cancer drug targets
Published: October 23, 2020
The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials.
Journal: Expert opinion on investigational drugs
Published: September 02, 2020
Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells.
Journal: Cancer gene therapy
Published: March 24, 2020
RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer.
Journal: Expert opinion on therapeutic targets
Published: December 27, 2019
Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells.
Journal: Journal of pediatric hematology/oncology
Published: February 01, 2019
Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib.
Journal: Targeted oncology
Published: November 18, 2018
Last Updated: 09/26/2026